A commenter commended CMS's commitment to developing the basis of payment for these new clinical diagnostic laboratory tests with the addition of CPT codes 0551U and 0568U
Additionally, there is no data addressing outcomes in patients who do not need weight loss but are using GLP-1 agonists solely to improve metabolic health
Reduced Inflammation Emerging research suggests GLP-1 therapies may help reduce chronic inflammation associated with metabolic disease
However, Ipamorelin and GHRP-6 are strictly for research purposes only and should not be used for human consumption
Of course, the benefits and side effects will differ slightly for everyone, depending on the dose, age, and other health factors
Anikster Y, Shotelersuk V, Gahl WA (1999) CTNS mutations in patients with cystinosis